Literature DB >> 16679405

Oxygen consumption and metabolite concentrations during transitions between different work intensities in heart.

Bernard Korzeniewski1.   

Abstract

Steady-state metabolite (ADP, ATP, P(i), PCr, and NADH) concentrations usually differ little between different workloads with significantly different oxygen consumption rates in the heart. However, during transitions between steady states, metabolite concentrations may in some cases change transiently, exhibiting a significant overshoot or undershoot, whereas in other cases they approach near-exponentially new steady-state values. Oxygen consumption rate usually reaches the new steady-state value very quickly (within a few seconds). The present in silico studies, performed using a previously developed computer model of oxidative phosphorylation in the heart, demonstrate that such a behavior of the oxidative phosphorylation system can be reproduced only under the assumption that ATP usage, substrate dehydrogenation, and (particular steps of) oxidative phosphorylation are directly activated to a similar extend by some cytosolic factor/mechanism during transition from low work to high work (the so-called parallel-activation mechanism). Computer simulations show that some differences observed between different experimental systems can be explained by a slightly different balance of the activation of particular components of the system and/or by a delay in time of the activation/inactivation of substrate dehydrogenation and oxidative phosphorylation during low-to-high and high-to-low work transitions. Thus the presented theoretical approach offers a general idea that is able to unify, at least semiquantitatively, different experimental data available in the literature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679405     DOI: 10.1152/ajpheart.00004.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Catalytic Coupling of Oxidative Phosphorylation, ATP Demand, and Reactive Oxygen Species Generation.

Authors:  Jason N Bazil; Daniel A Beard; Kalyan C Vinnakota
Journal:  Biophys J       Date:  2016-02-23       Impact factor: 4.033

2.  Computer-aided analysis of biochemical mechanisms that increase metabolite and proton stability in the heart during severe hypoxia and generate post-ischemic PCr overshoot.

Authors:  Bernard Korzeniewski
Journal:  J Physiol Sci       Date:  2011-06-11       Impact factor: 2.781

3.  Parallel activation of mitochondrial oxidative metabolism with increased cardiac energy expenditure is not dependent on fatty acid oxidation in pigs.

Authors:  Lufang Zhou; Marco E Cabrera; Hazel Huang; Celvie L Yuan; Duda K Monika; Naveen Sharma; Fang Bian; William C Stanley
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

4.  Role of NADH/NAD+ transport activity and glycogen store on skeletal muscle energy metabolism during exercise: in silico studies.

Authors:  Yanjun Li; Ranjan K Dash; Jaeyeon Kim; Gerald M Saidel; Marco E Cabrera
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-01       Impact factor: 4.249

5.  Faster and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart related to cytosolic inorganic phosphate (Pi) accumulation.

Authors:  Bernard Korzeniewski
Journal:  J Appl Physiol (1985)       Date:  2016-06-09

6.  Each-step activation of oxidative phosphorylation is necessary to explain muscle metabolic kinetic responses to exercise and recovery in humans.

Authors:  Bernard Korzeniewski; Harry B Rossiter
Journal:  J Physiol       Date:  2015-12-15       Impact factor: 5.182

7.  Regulation of cardiac cellular bioenergetics: mechanisms and consequences.

Authors:  Kenneth Tran; Denis S Loiselle; Edmund J Crampin
Journal:  Physiol Rep       Date:  2015-07

8.  Regulation of oxidative phosphorylation is different in electrically- and cortically-stimulated skeletal muscle.

Authors:  Bernard Korzeniewski
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.